daunorubicin has been researched along with trifluoperazine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (52.94) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Perchellet, JP; Satyamoorthy, K | 1 |
| Bindslev, N; Demant, EJ; Friche, E; Jensen, PB; Sehested, M; Skovsgaard, T; Vindeløv, L | 1 |
| Ganapathi, R; Grabowski, D; Israel, M; Schmidt, H; Seshadri, R | 1 |
| Akiyama, S; Kuratomi, Y; Kuwano, M; Nakagawa, M; Shiraishi, N | 1 |
| Cano-Gauci, DF; Riordan, JR | 1 |
| Ganapathi, R; Grabowski, D; Schmidt, H; Turinic, R; Valenzuela, R; Yen, A | 1 |
| Gordon, K; Krishan, A; Sauerteig, A; Swinkin, C | 1 |
| Ganapathi, R; Grabowski, D; Riegler, F; Rouse, W | 1 |
| Von Hoff, DD | 1 |
| Ayesh, S; Lan, LB; Lyubimov, E; Pashinsky, I; Stein, WD | 1 |
| Masui, H; Sakamoto, K; Wakabayashi, I; Yoshimoto, S | 1 |
| Broyles, TS; Charlier, HA; Cusack, BJ; Larson, CL; Mercer, WK; Muhlestein, DJ; Olson, DR; Olson, RD; Shadle, SE; Thornock, CM | 1 |
2 review(s) available for daunorubicin and trifluoperazine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for daunorubicin and trifluoperazine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Daunorubicin; DNA; Doxorubicin; Female; Mice; Neoplasms, Experimental; Ornithine Decarboxylase; RNA; Skin Neoplasms; Tetradecanoylphorbol Acetate; Time Factors; Trifluoperazine; Verapamil | 1989 |
Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Cycle; Cell Membrane; Daunorubicin; Drug Resistance; Polysorbates; Quinidine; Trifluoperazine; Tumor Stem Cell Assay; Verapamil; Vincristine | 1989 |
Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
Topics: Aminoacridines; Amsacrine; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Line; Dactinomycin; Daunorubicin; DNA; Doxorubicin; Drug Interactions; Drug Resistance; Leukemia P388; Leukemia, Experimental; Menogaril; Mice; Mitoxantrone; Naphthacenes; Nogalamycin; Trifluoperazine | 1985 |
Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine.
Topics: Calmodulin; Cell Line; Chlorpromazine; Daunorubicin; Drug Resistance; Humans; KB Cells; Lysosomes; Neoplasms; Thioridazine; Trifluoperazine; Tritium; Vincristine | 1986 |
Action of calcium antagonists on multidrug resistant cells. Specific cytotoxicity independent of increased cancer drug accumulation.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calcium; Calcium Channel Blockers; Cell Line; Cell Survival; Colchicine; Cricetinae; Daunorubicin; Drug Resistance; Humans; Kinetics; Mice; Nifedipine; Trifluoperazine; Verapamil; Vinblastine | 1987 |
Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells.
Topics: Animals; Cell Cycle; Cell Survival; Cells, Cultured; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice; Time Factors; Trifluoperazine | 1986 |
Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
Topics: Animals; Biological Transport; Cell Line; Chlorpromazine; Daunorubicin; Doxorubicin; Flow Cytometry; Fluorometry; Leukemia P388; Leukemia, Experimental; Mice; Monitoring, Physiologic; Trifluoperazine; Tumor Stem Cell Assay; Verapamil | 1986 |
Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
Topics: Animals; Biological Transport; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Trifluoperazine | 1984 |
Use of daunorubicin in patients with solid tumors.
Topics: Calcium Channel Blockers; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Neoplasms; Ricin; Trifluoperazine; Tumor Stem Cell Assay | 1984 |
Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Survival; Cyclosporine; Cytotoxins; Daunorubicin; Drug Resistance, Multiple; Humans; Propafenone; Trifluoperazine; Vinblastine | 1996 |
Daunorubicin-induced smooth muscle contraction: involvement of Ca2+ entry mechanism.
Topics: Animals; Antibiotics, Antineoplastic; Calcium; Calcium Channel Blockers; Daunorubicin; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Potassium Chloride; Trifluoperazine; Verapamil | 1997 |
Investigations of calsequestrin as a target for anthracyclines: comparison of functional effects of daunorubicin, daunorubicinol, and trifluoperazine.
Topics: Animals; Anthracyclines; Calsequestrin; Daunorubicin; Dogs; Dose-Response Relationship, Drug; Drug Delivery Systems; Myocardial Contraction; Rabbits; Trifluoperazine | 2005 |